S. Mohana Sundaram

Employment

• Pandorum Technologies Pvt Ltd Associate Research Scientist
  2025 - Present
• Manipal Institute of Regenerative Medicine Research Scholar
  2018 - 2024

Education

• Manipal Institute of Regenerative Medicine Ph.D.
  2018 - 2024
• Bangalore University MSc (Biotechnology)
  2013 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• The Activation of miR‐203a by SFRP4 Micropeptides Targets Epithelial–Mesenchymal Transition and Autophagy in Ovarian Cancer Stem Cells
  Molecular Carcinogenesis 2026 DOI: 10.1002/mc.70071
  +Save
• Mesenchymal stem cell‐derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs
  Drug Development Research 2023 DOI: 10.1002/ddr.22102
  +Save
• Short peptide domains of the Wnt inhibitor sFRP4 target ovarian cancer stem cells by neutralizing the Wnt β-catenin pathway, disrupting the interaction between β-catenin and CD24 and suppressing autophagy
  Life Sciences 2023 DOI: 10.1016/j.lfs.2023.121384
  +Save
• An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
  Cancers 2023 DOI: 10.3390/cancers15041275
  +Save
• Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
  Placenta 2022 DOI: 10.1016/j.placenta.2021.12.005
  +Save
• Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG
  Experimental Cell Research 2021 DOI: 10.1016/j.yexcr.2021.112912
  +Save